Endpoints launches its annual biopharma pay project; Andrew Dunn and Drew Armstrong break down CEO compensation live on June 9, 2026, at 12:30 pm ET on Post-Hoc Live.

Endpoints launches its annual biopharma pay project; Andrew Dunn and Drew Armstrong break down CEO compensation live on June 9, 2026, at 12:30 pm ET on Post-Hoc Live.

The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than the typical employee of an S&P 500 company.